InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: elichen post# 61353

Sunday, 02/23/2014 3:30:02 PM

Sunday, February 23, 2014 3:30:02 PM

Post# of 92948
Yes based on $2000 to $3000 per RPE treated eye, $4000 to $6000 for both eyes, $ACTC would fund all of its planned clinical trials for the 2nd Generation RPEs to treated myopic and wet AMD as well as other stem cells for cornea regeneration and other eye diseases.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.